Phase 2 biotech targeting acute ischemic stroke and chronic kidney disease.
Industry: Health Care
First Day Return: n/a
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 11/09/2018 |
Offer Price | $4.00 |
Price Range $4.00 - $5.00 | |
Offer Shares (mm) | 4.1 |
Deal Size ($mm) | $16 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 12/06/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $16 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Minneapolis, MN, United States |
Founded | 2000 |
Employees at IPO | 11 |
Website www.diamedica.com |